尼罗替尼
伊马替尼
髓系白血病
医学
肿瘤科
内科学
慢性粒细胞白血病
作者
Huifang Zhao,Huibing Dang,Lixin Liang,S. L. Guo,J L Chen,Shuxia Guo,Zhen Li,J. Wang,Xiaodong Lyu,Yongping Song,G L Zhang
出处
期刊:PubMed
日期:2024-11-05
卷期号:104 (41): 3830-3834
标识
DOI:10.3760/cma.j.cn112137-20240318-00612
摘要
To analyze the treatment-free remission (TFR) outcomes in patients with chronic myeloid leukemia (CML) treated sequentially with nilotinib (NIL) after achieving deep molecular response (DMR) to imatinib (IM).
科研通智能强力驱动
Strongly Powered by AbleSci AI